• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec25
ARK Investment by Cathie Wood Buys Shares of WeRide and CRISPR Therapeutics
03:51
Dec23
CRISPR Therapeutics AG CFO reports sale of company common stock
22:34
Needham Maintains Buy Rating on CRISPR Therapeutics
14:57
Dec22
CRISPR Therapeutics AG Launches Phase 1 Basket Trial for CAR T Therapy Zugo-cel
13:31
Dec9
Norwegian Bank Buys CRISPR Therapeutics Shares, CEO Cuts Holdings
11:22
Dec4
Rhumbline Advisers Acquired CRISPR Therapeutics AG Shares in Q2
10:55

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 889 K, Net Income -106.44 M, EPS -1.1699

Aug4
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 892 K, Net Income -208.55 M, EPS -2.4

May6
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 865 K, Net Income -136 M, EPS -1.5824

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More